BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.510
-0.005 (-0.33%)
At close: May 31, 2024, 4:00 PM
1.460
-0.050 (-3.31%)
After-hours: May 31, 2024, 5:42 PM EDT
BioAtla Stock Forecast
BCAB's stock price has decreased by -52.06% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for BioAtla stock have an average target of 12.75, with a low estimate of 5.00 and a high estimate of 25. The average target predicts an increase of 744.37% from the current stock price of 1.51.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioAtla stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +231.13% | May 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +363.58% | May 15, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +694.70% | Mar 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +363.58% | Mar 27, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +694.70% | Dec 5, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.68
from -2.58
EPS Next Year
-1.64
from -1.68
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 20.7M | 139.2M | 230.9M |
Avg | n/a | n/a | 20.1M | 98.8M | 194.9M |
Low | n/a | n/a | 19.3M | 66.7M | 165.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 592.9% | 133.7% |
Avg | - | - | - | 391.8% | 97.3% |
Low | - | - | - | 232.1% | 67.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.60 | -1.54 | -1.71 | -0.36 | 0.71 |
Avg | -1.68 | -1.64 | -1.77 | -1.63 | -0.75 |
Low | -1.75 | -1.71 | -1.80 | -2.80 | -2.11 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.